MLKL-IN-2
MLKL-IN-2 is a small molecule inhibitor targeting mixed lineage kinase domain-like protein (MLKL) to suppress necroptosis. It is a valuable research tool for investigating necroptosis-related pathologies, including inflammatory and neurodegenerative diseases, in both cellular and animal models.
Product Specifications
CAS Number
899759-16-1
Product Name Alternative
MLKL, MLKL IN 2, MLKLIN2, MLKL-IN-2
Field of Research
Signal Transduction
Purity
98.30% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.36 mM) ; DMSO:4.24 mg/mL (10.01 mM)
Smiles
CN1CCN (CC1) c1ccc (nn1) -c1cccc (NC (=O) c2ccc3ccccc3c2) c1
Molecular Formula
C26H25N5O
Molecular Weight
423.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
30262 96 Tests
Endothelial nitric oxide Synthase 3 (eNOS-3) Rat ELISA Kit
Sign In for Pricing
View Details 
MBS1060946-01 0.02 mg (E-Coli)
Recombinant Brucella canis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details MBS1060946-02 0.1 mg (E-Coli)
Recombinant Brucella canis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details MBS1060946-03 0.02 mg (Yeast)
Recombinant Brucella canis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details MBS1060946-04 0.1 mg (Yeast)
Recombinant Brucella canis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details